Syringe makers are scrambling to meet demand for so-called low dead space syringes as Pfizer and the U.S. look to squeeze out extra vaccine doses. The specialty needles are needed to eke out a sixth ...

Pharmac has secured a new supply agreement with Pfizer to continue funding the Comirnaty brand of COVID-19 vaccine. This means Comirnaty will remain the main funded vaccine in New Zealand from 1 ...

When pharmacists discovered a sixth dose could be pulled from vials of Pfizer and BioNTech’s vaccine, rather than the original five, it looked like a solution to supply-constrained vaccine rollouts.

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains 1 Shipping of the LP.8.1-adapted vaccine will ...

Korea Pfizer Pharmaceutical announced on the 4th that its COVID-19 vaccine "Comirnaty LP.8.1 pre-filled syringe" targeting the LP.8.1 variant received official approval from the Ministry of Food and ...

Slovakia does not only suffer from a lack of vaccines, but also a lack of suitable syringes with needles with what is called dead space. When compared to ordinary needles, there is less injected ...